Travere Therapeutics, Inc. (TVTX): Price and Financial Metrics

TVTX POWR Grades

• TVTX scores best on the Value dimension, with a Value rank ahead of 79.63% of US stocks.
• The strongest trend for TVTX is in Value, which has been heading up over the past 179 days.
• TVTX's current lowest rank is in the Sentiment metric (where it is better than 10.02% of US stocks).

TVTX Stock Summary

• TVTX's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 152.17 -- higher than 83.89% of US-listed equities with positive expected earnings growth.
• Of note is the ratio of Travere Therapeutics Inc's sales and general administrative expense to its total operating expenses; merely 20.25% of US stocks have a lower such ratio.
• TVTX's price/sales ratio is 7.24; that's higher than the P/S ratio of 80.28% of US stocks.
• If you're looking for stocks that are quantitatively similar to Travere Therapeutics Inc, a group of peers worth examining would be FBIO, RDCM, APM, BLDP, and CLVS.
• TVTX's SEC filings can be seen here. And to visit Travere Therapeutics Inc's official web site, go to www.retrophin.com.

TVTX Valuation Summary

• TVTX's EV/EBIT ratio is -6.7; this is 122.87% lower than that of the median Healthcare stock.
• TVTX's price/sales ratio has moved NA NA over the prior 106 months.
• Over the past 106 months, TVTX's price/earnings ratio has gone down 4.3.

Below are key valuation metrics over time for TVTX.

TVTX Growth Metrics

Its 3 year price growth rate is now at 26.58%.
• The 4 year cash and equivalents growth rate now stands at 188.11%.
• Its 2 year price growth rate is now at -43.44%.

Over the past 52 months, TVTX's revenue has gone up $77,404,000.

The table below shows TVTX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	227.49	-14.792	-180.091
2021-09-30	221.224	-1.785	-250.14
2021-06-30	204.146	-27.113	-237.05
2021-03-31	197.959	-40.062	-224.106
2020-12-31	198.321	-42.743	-169.431
2020-09-30	194.025	-33.365	-78.068

TVTX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• TVTX has a Quality Grade of C, ranking ahead of 60.91% of graded US stocks.
• TVTX's asset turnover comes in at 0.306 -- ranking 150th of 681 Pharmaceutical Products stocks.
• VTVT, FBRX, and NATR are the stocks whose asset turnover ratios are most correlated with TVTX.

The table below shows TVTX's key quality metrics over time.